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Reverse transcription is a complicated process that involves at least two cDNA transfer reactions to produce a full-length
copy DNA of the retroviral RNA genome. Because one retrovirus particle contains two identical genomic RNA molecules, the
transfers can occur in an intramolecular or intermolecular manner. The mechanism of the first transfer step (minus-strand
strong-stop cDNA transfer) has been studied previously in detail in transduction experiments with spleen necrosis virus
vectors containing genetic markers. Different results have been reported with respect to the type of strand transfer
mechanism. In this study, we analyzed the first strand transfer for human immunodeficiency virus type 1 (HIV-1). Two
genetically marked genomes were copackaged into virions and reverse transcription was initiated within these particles upon
permeabilization by NP-40 and addition of dNTPs. To test whether intrastrand or interstrand transfer had occurred, the cDNA
products of this endogenous reverse transcription reaction were extracted from the virions and analyzed for the presence
of restriction enzyme recognition sites provided by the genetic markers. The results of this analysis demonstrated that the
first DNA transfer reaction occurs in a random manner, with approximately the same contribution of intrastrand and
interstrand transfers. The ability to perform intermolecular strand transfer was lost upon extraction of the dimeric RNA
template from the virion particle. © 1998 Academic Press
Reverse transcription converts a retroviral RNA ge-
nome into double-stranded DNA that is termed the pro-
virus (1, 2). Retroviruses are able to synthesize a copy
DNA that is larger than the RNA template, thereby recon-
stituting sequences that are located upstream of the
transcriptional start site. This upstream region is criti-
cally important for subsequent transcription of the inte-
grated provirus as it encodes the transcriptional pro-
moter and enhancer signals. The production of a DNA
copy that is larger than the template RNA is mediated by
a complicated process that involves two cDNA transfer
reactions ((3), reviewed in (4)). Reverse transcription is
initiated by a cellular tRNA primer bound to the comple-
mentary primer-binding site (PBS) near the 59 end of the
viral RNA genome. An intermediate product is synthe-
sized, termed the minus-strand strong-stop cDNA, which
includes the R element present at the extreme 59 end of
the retroviral genome. Upon removal of the template RNA
sequences by the RNaseH activity of the RT enzyme, this
cDNA intermediate can transfer to the second copy of
the R element that is present at the extreme 39 end of the
genome. Subsequent elongation of minus-strand synthe-
sis, initiation of plus-strand synthesis, and a second DNA
transfer step are required to produce a full-length DNA
provirus (reviewed in (5)).
Because two identical RNA molecules are present as
a noncovalently linked dimer in a retrovirus particle, the
first DNA transfer reaction (also termed minus-strand or
strong-stop cDNA transfer) can occur in an intramolec-
ular or intermolecular manner. This mechanism has
been studied in detail in transduction experiments with
spleen necrosis virus (SNV) vectors that contain genetic
markers. Dissimilar results have been reported with re-
spect to the type of strand transfer. It was initially re-
ported that the first strand transfer reaction occurred
exclusively between the two packaged RNA genomes in
a pure interstrand manner (6), but another group ob-
served both intrastrand and interstrand transfers (7). Fur-
thermore, there is some evidence that the type of strand
transfer may differ among viral subpopulations (8), and a
similar observation has been reported for recombination
processes in general (9). In this study, we have analyzed
the first strand transfer reaction for the human immuno-
deficiency virus type 1 (HIV-1) by a more direct assay.
Two different RNA genomes were copackaged into virion
particles and reverse transcription was initiated within
the extracellular virions by permeabilization and addition
of dNTPs. The cDNA products of this endogenous re-
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verse transcription reaction were subsequently ex-
tracted, amplified by PCR, and analyzed for the presence
of restriction sites provided by the genetic markers. The
result of this analysis demonstrated that the first DNA
transfer reaction occurs in a random manner, with an
approximately equal contribution of intrastrand and in-
terstrand transfers.
The experimental system
Reverse transcription is initiated from a cellular tRNA
primer bound at the PBS site and two cDNA transfer
reactions are required to produce a full-length DNA copy
with two long terminal repeat (LTR) segments. There is
ample evidence that reverse transcription is initiated
within extracellular particles prior to infection of new
cells. For instance, most of the genome-associated
tRNALys3 primer in HIV-1 virions is in an extended form
(16, 17). However, reverse transcription is apparently
aborted before synthesis of the minus-strand strong-stop
cDNA is completed (18, 19, 20). This failure to elongate
reverse transcription is most likely because of a limita-
tion in the concentration of available deoxyribonucleo-
tides (dNTPs) (21, 22, 15). Reverse transcription can be
reinitiated within these particles by permeabilization of
the virion membrane with detergent and addition of a
high concentration of dNTPs. This reaction is termed the
endogenous reverse transcription assay and was used
in this study to examine the first DNA transfer event. The
major advantage of this intravirion reverse transcription
assay compared with the transduction experiments used
previously (6, 7) is that it is a more direct method to
measure reverse transcription. For instance, the trans-
duction type of experiments cannot rule out effects be-
cause of differences in the completion of reverse tran-
scription, integration, or subsequent steps.
To study the first strand transfer mechanism for the
HIV-1 virus, we used a replication-competent mutant of
the pLAI molecular clone with nucleotide substitutions in
the U3 and R regions of both 59 and 39 LTR elements (Fig.
1A). The mutation within the U3 element introduced an
AvaI or XhoI restriction enzyme recognition sequence,
and the mutation within R inserted a BglII site. The
rationale for using this mutant was as follows. If reverse
transcription is performed within heterozygous virions
that contain both a wild-type and mutant genome, the
genetically marked R and U3 segments will become
mixed upon interstrand transfer. Thus, a simple restric-
tion analysis of the cDNA would allow one to distinguish
between the two types of first strand transfer. Both the
mutations in the U3 and R region were previously dem-
onstrated to have no major effect on the virus replication
rate (11, 23). This may be surprising because the muta-
tion within R changes the bulge element of the TAR RNA
hairpin. This hairpin is critically involved in binding of the
Tat trans-activator protein (24). However, bulge sequence
variation (UCU and UUU) is observed frequently in nat-
ural HIV isolates (25) and was demonstrated to fully
support Tat-mediated activation of the viral LTR promoter
(26). Furthermore, we measured no major contribution of
the TAR element to packaging of the RNA genome into
virus particles (Das and Berkhout, unpublished results).
Another consideration in using this R region point muta-
tion instead of a larger substitution in this study was to
minimize any deleterious effects on the reverse tran-
scription process. In particular, sequence differences
between the donor and the acceptor R regions may
negatively affect the strand transfer efficiency, although
there is evidence that HIV-1 RT can efficiently translocate
with an acceptor R region that is much smaller than the
wild-type HIV-1 R element of 97 nucleotides (27).
The first strand transfer can occur either
intramolecularly or intermolecularly
The experimental protocol is illustrated in Fig. 2. The
cervix carcinoma cell line C33A was cotransfected with
the two HIV-1 molecular clones. To maximize the produc-
tion of heterozygous virus particles (Fig. 2), we used the
calcium phosphate transfection method that allows for
efficient cotransfection of cells with multiple DNA mole-
cules. The two HIV-1 plasmids were also transfected
individually to provide appropriate control samples. Vi-
ruses were harvested 3 days posttransfection and re-
verse transcription was performed within these particles
in the so-called endogenous assay. The viral cDNA was
subsequently extracted from the virions and the U3/R
region was PCR amplified and analyzed by diagnostic
restriction enzyme digestions. This direct PCR-mediated
analysis of the progeny DNAs allowed us to examine
large populations of reverse transcription products and
avoid sampling biases.
The HIV-1 DNA products that had completed the first
DNA transfer were selectively amplified by a set of prim-
ers located in the nef gene and the PBS site. PCR
amplifications were performed, and the resulting prod-
ucts were analyzed by agarose gel electrophoresis and
ethidium bromide staining to visualize the DNA product
(results not shown). When the DNA from dNTP-treated
virions was used as template for PCR amplification, a
discrete 827-bp DNA product was observed, which is the
size expected for a translocated DNA. Control virion
samples that were incubated without dNTPs did not
produce this DNA signal, indicating that the first DNA
transfer reaction was accomplished within the extracel-
lular particles upon the addition of dNTPs. A longer DNA
product of approximately 3000 bp could be detected in
the PCR samples. This product results from PCR ampli-
fication on the HIV-1 plasmids that were used for trans-
fection. Although the set of primers was designed to be
specific for translocated minus strand, amplification of
the input HIV-1 plasmids is possible because the 39 and
246 RAPID COMMUNICATION
59 LTR sequences are connected over the plasmid back-
bone. To exclude this plasmid-derived signal from the
subsequent restriction enzyme analysis, we eluted the
827-bp fragment from the gel and performed five addi-
tional PCR cycles in the presence of [a-32P]dCTP.
We next estimated what portion of progeny DNAs
arose from intramolecular and intermolecular strand
transfer by digesting the 32P-labeled 827-bp fragment
with the appropriate restriction enzymes. This approach
is complicated by the presence of a mixture of homozy-
gous and heterozygous virus particles (illustrated in Fig.
2). As discussed above, both HIV-1 genomes are tran-
scribed at similar levels, even though a single nucleotide
was substituted in the mutant TAR element (26). Thus,
approximately 50% of the virion will be heterozygous, and
the two homozygous virion forms will each constitute
25% of the virus population. If the first strand transfer is
purely intrastrand, even the heterozygous particles will
FIG. 1. Constructs used to analyze the first strand transfer mechanism. (A) Part of the HIV-1 U3-R sequences of the wild-type and mutant HIV-1
construct (11 denotes the transcription start site). A stretch of 17 nucleotides was mutated in the U3 region, thereby creating the AvaI/XhoI restriction
site. A BglII restriction site was introduced by single nucleotide substitution in the R region. (B) An outline of the restriction enzyme analysis of cDNA
products. HIV-1 cDNA products that performed the minus-strand DNA transfer and subsequent elongation were selectively PCR-amplified by a set
of primers located in the nef gene and the PBS site. This product, which encompasses the U3-R region, is shown on top. The presence of AvaI and
BglII restriction sites is indicated. Please note that upstream AvaII and BglII sites are present in the U3 region of all constructs, but the downstream
sites are diagnostic for the 1/1 mutant. The size of the DNA digestion products is indicated in nucleotides. Upon denaturing gel electrophoresis,
some fragments will show two DNA strands of different size due to the staggered cut by the restriction enzymes used. The bottom panel illustrates
the AvaI/BglII digestion pattern for all U3-R combinations (1/1, 1/2, 2/1, and 2/2). Each genotype will produce one unique DNA fragment, which
is marked by an asterisk. For instance, intrastrand transfer will lead to conservation of the wild-type and mutant genotypes (represented by the 2/2
and 1/1 signs), with unique DNA fragments of 361/357 and 26 nt, respectively. The 1/2 and 2/1 cDNA sequences, which result from interstrand
transfer, produce unique fragments of 209/205 and 178 nt, respectively. The ratio of these four unique fragments was analyzed in the subsequent
analyses (Fig. 3 and Table 1). The unique 178-nt fragment of the 2/1 genome was difficult to quantitate because of the overlap with the 179 fragment
that is produced by both the 1/1 and 2/1 genomes. To resolve this, we included the HindIII restriction enzyme in some of the subsequent analyses.
This enzyme cleaves the 183/179 fragment at position 177 of the R region, such that the unique 178-nt fragment can be detected more easily on the
gel. Because the introduced U3 restriction site is recognized by both AvaI and XhoI, we also used the latter enzyme in some of the assays. This
produces a different pattern of DNA fragments because XhoI does not recognize the upstream AvaI site.
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not produce U3/R recombinants. Thus, the total progeny
will have either both diagnostic U3/R restriction sites
(50% 1/1) or no sites (50% 2/2). On the other hand,
pure interstrand transfer will produce a progeny with a
fully mixed genotype (25% each of 1/1, 1/2, 2/1, and
2/2). If strand transfer occurs randomly, that is, 50%
interstrand and 50% intrastrand, we expect the following
ratio of genotypes (37.5% of both input forms 1/1 and
2/2 and 12.5% of the mixed genotypes 1/2 and 2/1).
The cleavage products for all four possible U3/R com-
binations upon AvaI/BglII double digestion are illustrated
in Fig. 1B. Several fragments are produced by all U3/R
combinations and are therefore noninformative (e.g., the
fragments of 138/142 and 329 nt). However, each U3/R
combination encodes one unique DNA fragment that
was labeled by an asterisk in Fig. 1B (e.g., the 1/2
genome produces the unique 209/205 signal). For a
quantitative analysis, we performed several restriction
analyses and focused on the ratio of these four unique
DNA products. The results of four independent restric-
tion enzyme digestion assays are summarized in Table 1.
This table also lists the expected ratios for the three
hypothetical strand transfer mechanism.
An example of a quantitative analysis of the DNA
digestion products is presented in Fig. 3. The digestion
pattern was compared for DNA derived from the two
control transfections with the individual plasmids (lanes
marked a and b) and the cotransfection (lanes marked c).
To comprehend the complex pattern of digestion prod-
ucts, we included control digestions with a single restric-
tion enzyme. Furthermore, we used both XhoI and AvaI
enzymes to screen for the presence of the U3 mutation.
Although several batches of the XhoI restriction enzyme
from different commercial sources were tested, a signif-
icant proportion of the DNA reproducibly failed to be
cleaved to completion. Obviously, incomplete digestion
FIG. 2. Production of heterozygous HIV-1 virions to study the mechanism of first strand transfer. Virions containing both the wild-type and mutant
RNA genome were produced by transiently transfected C33A cells. The presence or absence of diagnostic restriction sites in the 59 R and 39 U3
domains is indicated by the 22 and 11 signs, respectively. Only 50% of the virions are heterozygous, the remainder are homozygous for either the
22 or the 11 genome. Reverse transcription will connect the 39 U3 and 59 R regions and the absence or presence of restriction sites in these cDNA
domains is indicated by the 2/2 or 1/1 sign. This U3/R linkage is indicated for the three virion populations and three theoretical strand transfer
mechanisms (intrastrand, interstrand, or random). Obviously, the type of strand transfer will not affect the genetic linkage in the two homozygous virion
forms, but a different distribution of the restriction sites can be calculated for the heterozygous virions. The last column presents the expected
distribution of restriction sites in the U3/R region for the total progeny of each of the three strand transfer mechanisms.
TABLE 1
Ratioa of DNA fragments
1/1 1/2 2/1 2/2
Hypothetical DNA transfer
mechanisms
Intrastrand 1 0 0 1
Interstrand 1 1 1 1
Randomb 3 1 1 3
Endogenous reverse
transcriptionc
Expt. 1d 96 ndg 113 302
Expt. 2d 504 ndg 162 980
Expt. 3e 66 29 71 232
Expt. 4f 592 64 108 849
a Ratio of the four specific DNA fragments (marked with an * in Fig.
1B) that distinguish among the different DNA transfer mechanisms. The
hypothetical ratio is provided for three types of DNA transfer reactions.
The experimental ratio was determined in reverse transcription reac-
tions performed within virion particles (endogenous assay).
b Random means 50% intrastrand and 50% interstrand transfer.
c Specific DNA fragments were quantitated on a Phosphor Imager.
The relative counts were divided by the number of dCTP residues in
that particular DNA fragment (PCR primer sequences not included).
d AvaI/BglII digest with specific fragments of 26, 178, 209/205, and
361/357 nt.
e XhoI/BglII digest with specific fragments of 26, 507, 209/205, and
690/686 nt.
f AvaI/BglII/HindIII digest with specific fragments of 26, 178, 84, and 236 nt.
g Not determined because of overlap of the specific 178-nt fragment
with the 179-nt internal fragment.
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will impede a careful analysis of the undigested products
that have lost the U3/R restriction sites. We therefore
performed all subsequent assays with the AvaI enzyme.
Another technical difficulty was the quantitation of the
unique 178-nt fragment, because of the presence of an
internal 179-nt signal (Fig. 3, lane 15). To separate these
two signals, we included the HindIII restriction enzyme in
some digestions, which truncates the 179/183 internal
fragments (Fig. 1B).
Most importantly, we found evidence for interstrand
transfer by the appearance of unique DNA fragments in
the progeny of the cotransfection experiment. For in-
stance, the AvaI/BglII analysis of the cotransfected sam-
ple produces the unique 209/205 signal (Fig. 3, lane 15),
which was absent from the two single transfections
(lanes 13 and 14). However, this signal was not as in-
tense as several of the control fragments (e.g., the 138/
142 and 329-nt fragments), indicating that transfer did not
occur in a purely interstrand manner. The different sig-
nals were quantitated and corrected for the number of
dCTP incorporated per fragment. Although considerable
variation was observed among different digestion exper-
iments, this endogenous reverse transcription revealed a
ratio of the unique products that resembles the hypothet-
ical 3:1:1:3 ratio (Table 1). These results strongly suggest
that the first DNA transfer in HIV-1 occurs in a random
fashion, with an approximately balanced contribution of
the intramolecular and intermolecular transfer. In a sep-
arate set of experiments, we first extracted the RNA
genome from HIV-1 particles and then performed reverse
transcription by addition of dNTPs and the HIV-1 RT
enzyme. This assay yielded no fragments that are indic-
ative of an interstrand strand transfer mechanism, even
though the RNA genome was still in the native dimer
conformation (results not shown).
Previous studies with the SNV used constructs with
genetic markers to distinguish between interstrand and
intrastrand transfers of the minus-strand strong-stop
cDNA. It was initially reported that this first strand trans-
fer occurred exclusively between the two packaged RNA
genomes in an interstrand manner (6). However, another
group observed intrastrand as well as interstrand first
transfer (7). Both groups observed only intramolecular
transfer in the second transfer reaction, which was not
addressed in the current study with the HIV-1 retrovirus.
We used a more direct assay to study reverse transcrip-
tion in extracellular virions and found that both type of
transfers occur during minus-strand strong-stop cDNA
translocation. Furthermore, we determined the relative
frequency of the two sorts of strand transfer to be ap-
proximately 50% each. Because of this dramatically high
recombination efficiency, one can disregard a possible
contribution of DNA recombination that can occur be-
tween two cotransfected plasmids in our experimental
system.
Several obvious differences exist between our exper-
imental system and that used by others to analyze the
cDNA transfer reaction ((6, 7); see also the detailed
discussion in (5)). These differences include: (i) the type
of retrovirus; our study represents the first analysis with
HIV-1, previous studies were performed with vectors
based on SNV (6, 7); (ii) we used infectious HIV-1 virions
with a full-length RNA genome, whereas the other stud-
ies used transduction-competent retroviral vectors with
large insertions for selection markers; (iii) the reverse
transcription reaction was followed within virus particles
in our study, whereas a more indirect screening system
was used in the other studies, including the selection of
drug resistance in the transduced cells; (iv) unlike in our
study, one of the previous studies (7) used vectors with
inactivating mutations, such that recombination during
FIG. 3. Restriction enzyme analysis of reverse transcription products.
Virus particles were produced by C33A cells transfected with either the
wild-type construct (2/2, lanes marked a) or the mutant construct
(1/1, lanes b) or both DNA plasmids (2/2 and 1/1, lanes c). Reverse
transcription was performed within the virions by addition of dNTPs, the
DNA was subsequently extracted, and the U3-R region PCR-amplified.
This fragment was radiolabeled and digested with the restriction en-
donucleases indicated on top of the panel. The length of DNA frag-
ments is indicated in nt on the right. Most of the indicated DNA
fragments are present in the AvaI/BglII digest of lane 15, but some
length indications (481, 507, and 690/686 nt) refer to signals of the
XhoI/BglII digestion in lane 12 (these bands are marked with an aster-
isk). The DNA fragments that are unique for the 1/2 or 2/1 combi-
nation, which are formed exclusively by interstrand DNA transfer, are
indicated by an arrowhead. These bands were quantitated by Phosphor
Imager and used to calculate the ratio of interstrand to intrastrand
transfer. Please note that only the upper part of the sequencing gel is
shown, such that the unique 26-nt fragment is not visible.
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reverse transcription was required to produce progeny;
(v) unlike in our experiments, the other study (6) used a
1000-fold excess of one of the two genomes. Such ex-
perimental differences may explain the observation of
purely interstrand transfer in the initial study (6). More
importantly, the SNV study of Hu and Temin combined
with the current HIV-1 analysis strongly suggest that all
retroviruses use both intramolecular and intermolecular
first strand transfers. The observation that the isolated
RNA genome does not support an interstrand jump sug-
gests a facilitating role of the virion architecture.
It can be argued that mutation or reassortment of
the U3-R elements occurred during PCR amplification
of the progeny DNA. It seems impossible that sponta-
neous errors by Taq DNA polymerase could have gen-
erated these specific mutations at this high frequency.
However, it cannot be excluded that reassorted/hybrid
genomes were generated by PCR-mediated recombi-
nation between the wild-type and mutant DNA. In fact,
previous studies suggest that recombination during
PCR is a fairly common phenomenon (28, 29). To
minimize the chances for PCR-mediated recombina-
tion we used a PCR protocol with a minimal number of
cycli and maximal extension times. To further rule out
that the 1/2 and 2/1 genomes were generated dur-
ing PCR amplification, we performed one additional
experiment. The cDNA products of endogenous re-
verse transcription within wild-type and mutant virions
(derived from separate transfections) were mixed prior
to PCR amplification. The subsequent restriction en-
zyme analysis revealed no recombinant DNA products
(not shown). Furthermore, PCR analysis of the reverse
transcription products of the extracted HIV-1 RNA ge-
nome did not result in the appearance of recombina-
tion products (not shown). These combined results
rule out PCR artifacts.
A unique property of retroviruses is the presence of a
dimeric RNA genome, and an interstrand first transfer
may boost the recombination rate of these viruses. An
alternative mechanism was originally proposed to ex-
plain the extraordinary high recombination rate in retro-
viruses. It was suggested that retroviral RNA genomes
are frequently broken and that the RT enzyme, upon
encountering a break in the RNA template, can jump onto
the other RNA strand of the dimeric complex (30, 31).
This ‘‘forced copy choice transfer’’ may be mechanisti-
cally similar to the first strand transfer, and both mech-
anisms will lead to frequent recombination during retro-
virus replication. These mechanisms may increase the
genetic diversity in the virus population and may repair
lethal mutations (reviewed in (32, 33)). In addition, such
strand transfers were shown to increase the frequency of
base misinsertions (34, 35), which may provide the virus
with an extraordinary evolutionary capacity.
HIV-1 constructs and DNA transfection
The full-length infectious molecular clone pLAI was
kindly donated by Keith Peden (10). Introduction of the
Xho-10 mutation within the U3 region of both 59 and 39
LTRs was described previously (11). Because the mutant
LTR segment that was introduced into the pLAI clone
was derived from a different viral background (12), an
additional mutation was present in both LTRs at position
123 of the R region. These mutations in the U3 and R
regions create diagnostic XhoI/AvaI and BglII restriction
enzyme recognition sequences (illustrated in Fig. 1A).
C33A cervix carcinoma cells were grown in Dulbecco’s
modified Eagle’s medium supplemented with glucose,
MEM amino acids, and 10% fetal calf serum at 5% CO2
and 37°C. These cells were cultured to a subconfluent
monolayer in a 75-cm2 flask and transfected by the cal-
cium phosphate method as described previously (13). We
used 40 mg DNA per transfection (wild-type or mutant
pLAI molecular clone) and cotransfection was performed
with 20 mg of each plasmid.
Endogenous reverse transcription
The culture supernatant of transfected C33A cells was
harvested at day 3 posttransfection and used as a
source of virions for the endogenous RT assay. This
assay allows reverse transcription to proceed within
permeabilized virus particles and was performed accord-
ing to Schwartz et al. (14) with some minor deviations
(15). The synthesized cDNA was extracted from the virion
particles, precipitated with NaAc/ethanol, and dissolved
in 20 ml TE buffer (10 mM Tris–HCl, pH 8.0, 1 mM EDTA),
of which 5 ml was used for PCR amplification of the HIV-1
U3-R region.
PCR amplification of progeny DNA, labeling, and
restriction enzyme digestion
DNA products of the endogenous and exogenous as-
say were amplified by PCR, with a 59 primer identical to
nef sequences located upstream of the U3 region (NEF-
SEQ2, positions 8961 to 8970 on pLAI) and a 39 primer
complementary to the PBS site just downstream of the
U5 region (Lys21, positions 636 to 656). The PCR was
performed in 100 ml standard buffer with 800 mM dNTPs
as follows: 25 cycles (1 min at 95°C, 1 min at 55°C, and
2 min 72°C) and final extension for 10 min at 72°C. Ten
microliters was analyzed on a 1% agarose gel and the
827-basepair (bp) U3-R product was purified by USBio-
Clean MP extraction (USB Biochemicals). This product
was solubilized in 20 ml, of which 5 ml was used for 5
additional PCR cycles in the presence of [a-32P]dCTP (1
ml of specific activity 3000 Ci/mmol, 10 mCi/ml, Amer-
sham) and 80 mM unlabeled dNTPs. The labeled DNA
was purified on an agarose gel, eluted, and used for
restriction enzyme digestions in the buffer provided by
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the manufacturer. The digestion products were mixed
with an equimolar amount of formamide sample buffer,
heated at 95°C, and analyzed on a denaturing 6% urea–
polyacrylamide gel. Gels were exposed to X-ray film and
analyzed with a PhosphorImager (Molecular Dynamics)
to quantitate specific DNA bands.
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